AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Pellicciari, R Costantino, G Marinozzi, M Macchiarulo, A Amori, L Flor, PJ Gasparini, F Kuhn, R Urwyler, S
Citation: R. Pellicciari et al., Design, synthesis and preliminary evaluation of novel 3 '-substituted carboxycyclopropylglycines as antagonists at group 2 metabotropic glutamate receptors, BIOORG MED, 11(24), 2001, pp. 3179-3182

Authors: Urwyler, S Mosbacher, J Lingenhoehl, K Heid, J Hofstetter, K Froestl, W Bettler, B Kaupmann, K
Citation: S. Urwyler et al., Positive allosteric modulation of native and recombinant,gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501, MOLEC PHARM, 60(5), 2001, pp. 963-971

Authors: Neijt, H Koller, M Urwyler, S
Citation: H. Neijt et al., Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity, BIOCH PHARM, 61(3), 2001, pp. 343-349

Authors: Galvez, T Urwyler, S Prezeu, L Mosbacher, J Joly, C Malitschek, B Heid, J Brabet, I Froestl, W Bettler, B Kaupmann, K Pin, JP
Citation: T. Galvez et al., Ca2+ requirement for high-affinity gamma-aminobutyric acid (GABA) binding at GABA(B) receptors: Involvement of serine 269 of the GABA(B)R1 subunit, MOLEC PHARM, 57(3), 2000, pp. 419-426

Authors: Gasparini, F Lingenhohl, K Stoehr, N Flor, PJ Heinrich, M Vranesic, I Biollaz, M Allgeier, H Heckendorn, R Urwyler, S Varney, MA Johnson, EC Hess, SD Rao, SP Sacaan, AI Santori, EM Velicelebi, G Kuhn, R
Citation: F. Gasparini et al., 2-methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist, NEUROPHARM, 38(10), 1999, pp. 1493-1503

Authors: Gasparini, F Bruno, V Battaglia, G Lukic, S Leonhardt, T Inderbitzin, W Laurie, D Sommer, B Varney, MA Hess, SD Johnson, EC Kuhn, R Urwyler, S Sauer, D Portet, C Schmutz, M Nicoletti, F Flor, PJ
Citation: F. Gasparini et al., (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo, J PHARM EXP, 289(3), 1999, pp. 1678-1687
Risultati: 1-6 |